Paul Edward Kelly, Director at RELMADA THERAPEUTICS, INC. (RLMD), sold 10,000 shares at $30.04 ($300K) on 2022-04-04, disclosed to the SEC on 2022-04-05.
Open-market sale of $300k RLMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RLMD | BUY | 2024-09-11 | $65K | — | Filing → |
| RLMD | SELL | 2021-03-11 | $357K | — | Filing → |
| RLMD | SELL | 2021-02-26 | $338K | — | Filing → |